Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ericsson (ERIC) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alexander Duval citing his view that its fundamentals are solid in Networks, Digital Services and Managed Services but the stock has pulled back by about 5% relative to the others in EU Tech since the company's Q2 report on July 17. 2. AB InBev (BUD) upgraded to Buy from Neutral at BofA/Merrill with analyst Fernando Ferreira saying the cycle of downward earnings revisions is coming to an end. 3. Volaris (VLRS) upgraded to Overweight from Equal Weight at Barclays with analyst Pablo Monsivais saying he sees share upside given the company's "simple model" that drives the lowest possible costs. 4. NXP Semiconductors (NXPI) upgraded to Outperform from In Line at Evercore ISI. 5. Gilead (GILD) upgraded to Top Pick from Outperform at RBC Capital with analyst Brian Abrahams saying the stock represents a "compelling opportunity" with limited downside risks as the company's HIV franchise generates a "steady" annual revenue of about $16B per year over the medium term given the "very strong" uptake of its Biktarvy, according to prescription data. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSAudioEye (AEYE) up... To see the rest of the story go to thefly.com. See Story Here

Volaris is up 13.7%, or $1.09 to $9.12.

Sees FY24 EBITDAR margin 32%-34%. Sees FY24 capital expenditures $400M. Sees FY24 average jet fuel price $2.60-$2.70.

Cantor Fitzgerald lowered the firm's price target on Gilead to $75 from $78 and keeps a Neutral rating on the shares. The firm, which made slight adjustments to all of its large-cap biotechnology models ahead of Q1 earnings season for the group, lowered its target for Gilead given slower expected HIV growth. The "usual seasonal headwinds that typically make this one of the weaker quarters for the industry," the analyst added in the preview note.